In patients with metastatic malignant melanoma, the combination of ipilimumab ( CTLA4 antibody) and programmed death (PD)-1 inhibitor nivolumab can significantly improve the prognosis compared with ...
Compared with other malignant tumors such as non-small cell lung cancer (NSCLC) and breast cancer, head and neck squamous cell carcinoma (HNSCC) is relatively rare in the United States. There are abo...
Mr. Xu is a typical Chongqing native. He is naturally spicy and unhappy. Among all the spicy foods, Chongqing spicy hot pot is his favorite. However, unfortunately, a malignant tumor with a parotid ...
People are familiar with the uncomfortable feeling of acid reflux. A recent US study found that gastroesophageal reflux disease (GORD) may increase the risk of laryngeal cancer , tonsil, and some s...
The University of Athens Strati A et al. reported that whether PD-L1 is overexpressed in circulating tumor cells (CTC) can provide more feasible and important prognostic information for patients wit...
The report by Kershena Liao of Baylor College of Medicine in the United States and more fully understand the process of head and neck oncologists considering switching to palliative care, which can ...
Experts from CancerFax can assist patients in directly consulting with experts in major proton centers to determine the suitability of patients for proton therapy. At the same time, they can assist pa...
The research team of Shenzhen Hospital collected 37 samples of bladder cancer patients, performed whole exon sequencing and gene editing techniques, and discovered the culprit of bladder cancer recurr...
Gastrointestinal stromal tumor targeting drug Avapritinib (Avapriny, Ayvakit, BLU-285) is approved by USFDA on 9th January, 2020. The drug covers two indications: for the treatment of adult patients ...
Colon cancer immunotherapy, rectal cancer immunotherapy, colorectal cancer immunotherapy, and colorectal cancer PD-1 / PD-L1 treatment. Seventeen years ago, the number of drugs available for advanced...